Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 23Lymphoma, Non-Hodgkin 22Lymphoma, Large B-Cell, Diffuse 16Hodgkin Disease 16Lymphoma, Mantle-Cell 13Lymphoma, Follicular 13Burkitt Lymphoma 9Multiple Myeloma 7Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, B-Cell 6Glioblastoma 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Gliosarcoma 4Glioma 4Recurrence 3Neoplasms, Plasma Cell 3Neoplasms 3Leukemia, Myeloid, Acute 3Congenital Abnormalities 3Astrocytoma 3Waldenstrom Macroglobulinemia 2Primary Myelofibrosis 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Myelodysplastic Syndromes 2

Interventions

Etoposide 4Vincristine 3Rituximab 3Prednisone 3Doxorubicin 3Cyclophosphamide 3prednylidene 2deltacortene 2Cytarabine 2varlilumab 1merphos 1ixazomib 1carmustine, poliferprosan 20 drug combination 1belantamab mafodotin 1Vorinostat 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Methotrexate 1Melphalan 1Immunoglobulin G 1Hydrocortisone 1Disulfides 1Carmustine 1CT-P10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Plasmablastic Lymphoma × Carmustine × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡